Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 69097-967

This is a medication description for Sevelamer tablets. Each film-coated tablet contains 800mg Sevelamer. The inactive ingredients include microcrystalline cellulose, silicon dioxide, hydroxypropyl methylcellulose, talc and more. This medication is for prescription only and the recommended dosage should be according to the package insert. It should be stored in a tight and light-resistant container at 20-25°C. The medication is manufactured by Invagen Pharmaceuticals and sold by Cipla USA.*

This appears to be a chart or graph showing the reduction in serum phosphorus levels in patients receiving a medication called Sevelamer Hydrochloride compared to an active control group. The chart displays the percentage of patients who experienced improvement in their serum phosphorus levels (reduction from baseline) with Sevelamer Hydrochloride compared to the control group. The X-axis shows a scale of reductions in serum phosphorus levels (in mg/dL).*

Sevelamer Carbonate Tablets is a prescription drug consisting of 270 film-coated tablets, each containing 800 mg of sevelamer carbonate. It is produced by Cipla and is used as per the dosage information specified in the package insert. The tablet's inactive ingredients include microcrystalline cellulose, silicified microcrystalline cellulose, crospovidone, hydroxy propyl cellulose, talc, colloidal silicon dioxide, sodium stearyl fumarate, hydroxypropyl methyl cellulose, and diacetylated monoglycerides. The drug should be kept in a tightly sealed, light-resistant container as defined in the USP and protected from moisture. It must be stored at 20° to 25°C (68° to 77°F), according to USP controlled room temperature guidelines. Cipla Ltd. of Kurkumbh, India, produces the medication for Cipla USA, Inc. at their Independence Boulevard site in Warren, NJ 07059. However, the provided text does not state the condition that the drug is meant to treat.*